Skip to main content

GIC Private Ltd's Form 4 filing

Medline Inc. (MDLN) · filed Aug 7, 2026

Accession no.
0001193125-26-340273
Filed
Aug 7, 2026, 4:15 PM ET
Trade date
Aug 5-6, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market sales total $80.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
GIC Private LtdCIK 000093682810% Owner
GIC Special Investments Pte LtdCIK 000129621210% Owner
Hux Investment Pte. Ltd.CIK 000203848310% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 5, 2026Class A Common StockSSaleDisposed−1,710,907$35.46F1−$60,668,762.2225,530,471Direct
Aug 5, 2026Class A Common StockSSaleDisposed−265,711$36.48F3−$9,693,137.2825,264,760Direct
Aug 6, 2026Class A Common StockSSaleDisposed−271,994$35.33F4−$9,609,548.0224,992,766Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.08 to $35.99, inclusive. The reporting person undertakes to provide to Medline Inc., any security holder of Medline Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.72, inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.90, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)